BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 30, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Nesina alogliptin regulatory update

Japan's Ministry of Health and Welfare approved Takeda's Nesina alogliptin for use in combination with thiazolidinediones to treat Type II diabetes. The once-daily didpeptidyl peptidase-4...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >